Ana Paula Gomes Alcântara Villa Nova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ana Paula Gomes Alcântara Villa Nova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Batista Alves
Clínica AMO, Salvador, BA, Brasil
1 shared publication - Aknar Calabrich
Clínica AMO - Department of Clinical Oncology , Salvador
1 shared publication - Alex Pimenta da Silva
Clínica AMO, Salvador, BA, Brasil
1 shared publication - Ana Paula Laranjeira Fernandes
Clínica AMO, Salvador, BA, Brasil
1 shared publication Anelisa K. Coutinho
Clínica AMO, Salvador, BA, Brasil
1 shared publication- Bianca Vivas Fiscina
Clínica AMO, Salvador, BA, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 March 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (3) , 338-344
Oncology practice during COVID-19 pandemic: a fast response is the best response
SUMMARY The first confirmed case of coronavirus disease 2019 (COVID-19) in Brasil was reported on February 25th, 2020, and by April 3rd, 8076 were confirmed in the country. As COVID-19 disease incidence escalates in Brasil, management of cancer patients requires immediate action and oncology clinics are urged to establish a contingency plan. We have installed a COVID-19 Management Committee to elaborate and implement best practices to assist cancer outpatients as well as to provide a safe environment for clinical staff and other employees at the outpatient clinics. The challenges of cancer treatment in the midst of COVID-19 global pandemic highlight the importance of a rapid response by institutions, where organizational structure, strategic planning, agility in guidelines implementation and alternative ways to protect and support clinical staff, employees and patients may be the key to mitigate pandemic effects.
- 1 March 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (3) , 338-344
Open AccessOncology practice during COVID-19 pandemic: a fast response is the best response
SUMMARY The first confirmed case of coronavirus disease 2019 (COVID-19) in Brasil was reported on February 25th, 2020, and by April 3rd, 8076 were confirmed in the country. As COVID-19 disease incidence escalates in Brasil, management of cancer patients requires immediate action and oncology clinics are urged to establish a contingency plan. We have installed a COVID-19 Management Committee to elaborate and implement best practices to assist cancer outpatients as well as to provide a safe environment for clinical staff and other employees at the outpatient clinics. The challenges of cancer treatment in the midst of COVID-19 global pandemic highlight the importance of a rapid response by institutions, where organizational structure, strategic planning, agility in guidelines implementation and alternative ways to protect and support clinical staff, employees and patients may be the key to mitigate pandemic effects.